Single-use Assemblies Market Size, Share, Trends Report Segmented by Product (Bag, Bottle & Tubing Assemblies), Application (Filtration, Storage, Sampling), Solution (Customized, Standard), End User (Biopharma Companies, CROs) Industry Analysis & Regional Forecast to 2031

Single-use Assemblies are engineered fluid handling configurations designed to support the sterile transfer of materials across biopharmaceutical manufacturing workflows. These assemblies integrate tubing, connectors, filters, and other disposable components into closed systems that maintain process integrity throughout upstream and downstream operations. Their use reduces reliance on fixed stainless-steel infrastructure, enabling manufacturers to operate more flexible production environments while minimizing contamination risks. As biologics pipelines become more diverse and batch sizes more variable, single-use assemblies have become a practical solution for managing complex fluid pathways with consistent quality control.

Advantages of single-use assemblies bolster their demand

The increasing adoption of single-use assemblies is closely linked to their ability to simplify manufacturing operations. Bioprocessing end users usually undertake the in-house assembling of single-use systems; however, incorrect connections between the various components might result in cross-contamination and leakage which in turn might lead to production delays. Pre-designed and pre-tested single-use assemblies mitigate these risks by offering standardized, ready-to-install solutions that improve reliability and process control.

Some of the key benefits that are driving its demand are:

• Faster implementation of single-use assembly components in the bioprocess cycle
• Lower risks of cross-contamination and leakage
• Reduced labour, expense, and time for end-users, resulting in cost reduction
• Eliminates cleaning and downtime
• Water and energy cost reduction
• Quality and documentation control
• Increased overall manufacturing efficiency

By eliminating cleaning, sterilization, and validation steps, these assemblies help reduce turnaround time between production runs. This operational efficiency is vital for facilities managing multiple products or frequent changeovers. Furthermore, disposable fluid paths support faster facility commissioning and lower utility consumption, making them well-suited for both new capacity expansions and retrofitting of existing plants.

To learn more about this report, download the PDF brochure

Growing adoption of flexible and modular production facilities

Single-use assemblies contribute to improved process consistency by enabling standardized fluid handling across repeated production runs. When integrated with single-use bioreactors and disposable containers, these assemblies help reduce variability introduced by cleaning, sterilization, and equipment reuse. This is especially relevant for multi-product facilities and contract manufacturing environments, where rapid changeovers and process flexibility are required.

From an operational perspective, the pre-validated assemblies simplify setup and reduce downtime, enabling manufacturers to focus their resources on process optimisation rather than equipment preparation. Additionally, standardized assembly designs enable easier replication of fluid pathways across sites, supporting multi-site manufacturing strategies and global production alignment. The consolidation of fluid transfer functions within disposable assemblies also supports better documentation and traceability, which is critical for regulatory compliance and quality assurance.

Beyond large-scale commercial production, single-use assemblies are increasingly used in process development, pilot-scale manufacturing, and clinical production settings. In these stages, flexibility and speed are prioritized, and disposable systems allow rapid configuration changes without extensive revalidation. Researchers and process engineers benefit from assemblies that can be easily adapted to evolving process requirements while maintaining sterility and material compatibility. This broader adoption across development stages supports smoother scale-up from early research to commercial manufacturing, reducing technology transfer challenges and helping ensure continuity in fluid handling design as products progress through the pipeline.

Market growth catalysts beyond operational advantages

In addition to the functional benefits of single-use assemblies, the broader expansion of complementary single-use technologies, such as single-use bioreactors and bioprocess containers, is reinforcing market growth by creating more integrated and scalable manufacturing solutions. Single-use bioreactors are increasingly preferred due to their flexibility, reduced need for validation, and rapid changeover times that support diverse product pipelines- trends that enhance the attractiveness of modular bioprocess workflows. Similarly, the strong growth trajectory of the bioprocess containers market, driven by ready-to-use container systems that reduce operational expenses and support scalability from lab to production scale, underscores the shift toward fully disposable production environments. This convergence of single-use assemblies with other disposable technologies helps strengthen the overall single-use ecosystem, enabling manufacturers to adopt flexible, efficient, and cost-effective bioprocess platforms across multiple stages of biologics and vaccine production.

“In bioprocessing, there are several advantages of single-use technology, but making it work requires access to the necessary tools—and lots of them. A single-use assembly provides everything a bio processor requires: bags, tubing, connectors, and filters. It provides flexible, customized single-use solutions to accelerate pharmaceutical drug development and manufacturing. Ready-to-use assemblies allow the development and production of products in a wide range of sizes and for a variety of diseases. It is a critical component in the supply chain for the production of vaccines and medications around the world”

- Senior Director, Leading Single-use Assembly Manufacturer, United States

Risk of leachables from single-use assembly products – a deterrent for market growth

Single-use assembly products are made of processed plastic materials, and they frequently face the risk of contamination from the container due to leachables. Leachables are chemical compounds that migrate into the drug formulation from any product contact material (such as elastomeric, plastic, glass, stainless steel, or coating components) as a result of direct contact with the drug formulation under normal process conditions or accelerated storage conditions and are found in the final drug product.

Leachables are a source of process-related impurities that have the potential to alter the product quality of biotherapeutics and affect patient health. However, despite these challenges, single-use technologies are expected to grow as suppliers & end-users are working together on this issue. Proper risk assessments, characterization of extractable profiles according to standardized protocols, toxicological assessments, leachable studies, and mature guidance guidelines are some of the mitigation steps undertaken by stakeholders to confront the problem of leachables.

To learn more about this report, download the PDF brochure

Application Segment Outlook

Filtration is the largest application segment within the single-use assemblies market, as it's vital in both upstream and downstream bioprocessing for clarification, sterilization, and buffer preparation. The growing adoption of disposable filtration assemblies is driven by the need for robust contamination control while reducing turnaround times at multi-product manufacturing facilities. Cell culture and mixing applications also hold a significant share, supported by the growing production of biologics and advanced therapies. Single-use assemblies used in these processes enable efficient media and buffer handling, flexible batch sizing, particularly when used with single-use bioreactors. Storage and sampling applications are steadily gaining importance as manufacturers adopt disposable containers and closed sampling systems to maintain sterility and process integrity. These applications support in-process monitoring without disrupting aseptic conditions. Fill-finish applications, which represent a smaller market share, are gaining traction in clinical and small-scale commercial manufacturing, where sterility assurance and operational flexibility are critical.

Regional Outlook: North America is expected to maintain a leading position

North America holds a leading position in the single-use assemblies market, supported by a strong biopharmaceutical manufacturing base, ongoing capacity expansions, early adoption of disposable technologies, and presence of major players in the region. Europe represents another important market, driven by established biologics production hubs and regulatory emphasis on quality and contamination control. The Asia Pacific region is expected to experience the fastest growth over the forecast period, supported by increasing investments in biologics manufacturing, the expansion of local CDMOs, and improving healthcare infrastructure.

Competitive Landscape Analysis

The global single-use assemblies market is characterized by the presence of established and emerging market players, including Thermo Fisher Scientific, Inc.; Merck KGaA; Sartorius AG; Danaher Corporation; Avantor; Lonza; Saint-Gobain; Corning Incorporated; Entegris; and KUHNER AG, among others. Some of the key strategies adopted by market players include product innovation and development, strategic partnerships and collaborations, mergers and acquisitions, and geographic expansion.

Get a sample report for competitive landscape analysis

Report Scope

Global Single-use Assemblies Market Segmentation

This report by Medi-Tech Insights provides the size of the global single-use assemblies market at the regional and country-level from 2024 to 2031. The report further segments the market based on product, application, solution, and end-user.

Market Size & Forecast (2024-2031), By Product, USD Billion

• Bag Assemblies
• 2D Bag Assemblies
• 3D Bag Assemblies
• Filtration Assemblies
• Bottle Assemblies
• Tubing Assemblies
• Others

Market Size & Forecast (2024-2031), By Application, USD Billion

• Filtration
• Cell Culture & Mixing
• Storage
• Sampling
• Fill-finish Applications
• Others

Market Size & Forecast (2024-2031), By Solution, USD Billion

• Customized Solutions
• Standard Solutions

Market Size & Forecast (2024-2031), By End-user, USD Billion

• Biopharmaceutical Companies
• Academic & Research Institutes
• CROs
• Others

Market Size & Forecast (2024-2031), By Region, USD Billion

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Related Reports:

Global Bioreactors Market Size & Trends Report Segmented by Type (Single-Use, Stirred-Tank, Airlift), Material (Glass, Stainless Steel, Single-Use), Usage (Lab-Scale, Pilot-Scale, Large-Scale), End-user (Biopharmaceutical Companies, CMOs) & Regional Forecast to 2030

Sterilization Services Market (2026-2031) Size, Share, Analysis By Method (Gamma Sterilization, Steam Sterilization, Ethylene Oxide (ETO) Sterilization), Business Type (Contract Sterilization Services, Sterilization Validation Services), End User (Hospitals, Clinics, Biotechnology companies) Region and Segment Forecast to 2030